Continuous Diaphragm Monitoring to diagnose respiratory disorders and clinically validate enhanced weaning of ventilated patients

Extended mechanical ventilation in hospital intensive care units (ICUs) account for 6% of all ventilated patients, but consume 37% of ICT resources which leads to $20 billion surplus burden on European and US healthcare system each year. Moreover, the int ensive care demand is projected to increase significantly in the next few decades due to the impact of ageing population, making the provision of critical healthcare unsustainable. The DiaMon project addresses this socio-economic need, and provides a hig hly relevant and realistic R&D innovation for this troubled health care domain. Based on early discovered imaging biomarker Lung Sinus, NeoRad AS proses development and clinical validation of anew monitoring and diagnostic medical device, which supports w eaning, thereby avoiding the extended mechanical ventilation, and as a result admittance in ICUs. The success of DiaMon will deliver: 1) to patients - safer and earlier weaning from a respirator, less morbidity, improved quality of life by avoidance of mechanical ventilation side effects 2) to Medical staff - a technology providing a continuous and real time monitoring of breathing performance which will enhance their performance by improving day- to-day extubation decision making 3) to health care syst ems- sustainability through efficient delivery of service and reduction in healthcare bills 4) to NeoRad - increased growth performance and profitability.